BPG is committed to discovery and dissemination of knowledge
Meta-Analysis
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Mar 27, 2026; 18(3): 116913
Published online Mar 27, 2026. doi: 10.4240/wjgs.v18.i3.116913
Table 4 Comparative outcomes and risk of bias across studies
Ref.
Effect size
95%CI
P value
Secondary outcomes
Subgroup analyses/notable findings
Risk of bias
Notes
Jin et al[12], 2016NR (no OR/RR for recurrence in abstract)Lower blood loss (LLH vs OLH)2; lower transfusion1No significant difference in recurrence/complications between LLH and OLHSome concernBenefit in perioperative metrics; recurrence not different
Tsutsumi et al[13], 2017AE difference (sDBE 10% vs PTCS 45%)10.025LOS shorter with sDBE2 (10 days vs 35 days; P < 0.001)Stone-free survival similar (P = 0.919)Some concernDirect method comparison after HJ; crossover allowed
Ishihara et al[14], 2021NR (author multivariable HRs for recurrence reported in text)Clearance, AEs, re-intervention reportedMultivariable model for recurrence riskSome concernTime-to-event recurrence over approximately 30 months
Torres et al[15], 2021Recurrence proportion 7.8%Complications 33.0%; mortality 0.7%Higher recurrence in bilateral stones/HJSome concernMulticenter non-Asian surgery cohort
Yan et al[16], 2024Clearance 90.48%; recurrence 28.57%-MELD improvement2 (P < 0.05); survival describedDecompensated cirrhosis; transplant eligibilityHigh risk (small n, severity)High-risk population; detailed follow-up
Hakuta et al[17], 2024OR 10.4 (failed removal in past HJS)2.99-36.5AEs 9.9%; recurrence 17%, 20%, 31% at 1/3/5-yearPast HJS (> 10 years) drives technical failureSome concernLarge HJS cohort; Kaplan-Meier recurrence


Write to the Help Desk